Lane Lambert

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Berkshire Hathaway reports strong Q3 results, but Buffett to step down as CEO, raising questions about the company's future capital allocation decisions.
  • The Associated Press, a trusted global news organization, reaches over half the world's population daily with its fast, accurate, and unbiased reporting.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Berkshire Hathaway reports strong Q3 results, but Buffett to step down as CEO, raising questions about the company's future capital allocation decisions.
  • The Associated Press, a trusted global news organization, reaches over half the world's population daily with its fast, accurate, and unbiased reporting.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Lane Lambert